CD4 and neoplasm: Furthermore, we noted that the proportions of tumor-reactive CD8 + and CD4 + FoxP3- T-cells were similar, except for MM, which had significantly fewer tumor-reactive CD4 + FoxP3- T-cells than in NSCLC.